NCT00375492 - Effect on Weight Loss of Exenatide Versus Placebo | Biotech Hunter

Enrollment

196

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

exenatide

subcutaneous injection, 5mcg or 10mcg, twice a day

DRUG

placebo

subcutaneous injection, volume equivalent to exenatide dose, twice a day

Trial Locations (10)

Research Site, Peoria

Research Site, Jacksonville

Research Site, Orlando

Research Site, Indianapolis

Research Site, Boston

Research Site, Minneapolis

Research Site, St Louis

Research Site, Spartanburg

Research Site, San Antonio

Research Site, Renton